Je was op zoek naar: intermedius, intermedius (Engels - Lets)

staphylococcus intermedius
staphylococcus intermedius

crocodylus intermedius (i)
crocodylus intermedius (i)

escherichia coli staphylococcus intermedius
escherichia coli staphylococcus intermedius

crocodylus intermedius (i) orinoco crocodile
crocodylus cataphractus (i)

superficial pyoderma caused by staphylococcus intermedius.
staphylococcus intermedius ierosinātas virsējās piodermas ārstēšanai.

staphylococcus intermedius group (including s. pseudintermedius)
staphylococcus intermedius grupa (t.sk. s.pseudintermedius)

bacterial pathogen staphylococcus intermedius β haemolytic streptococcus spp.
staphylococcus

pasteurella multocida, escherichia coli and the staphylococcus intermedius group (including
staphylococcus intermedius grupas (t.sk. s.pseudintermedius) celmi, ārstēšanai.

pathogen e coli enterococci proteus mirabilis pseudomonas aeruginosa staphylococcus intermedius streptococcus ß-haemolyticus g
patogēns e coli

streptococcus anginosus group (includes s. anginosus, s. intermedius, and s. constellatus).
streptococcus anginosus grupa (tostarp s. anginosus, s. intermedius un s. constellatus)

cefovecin exhibits in vitro activity against staphylococcus intermedius and pasteurella multocida which are associated with canine and feline skin infections.
in- vitro cefovecīns darbojas pret staphylococcus intermedius un pasteurella multocida, kuras izraisa ādas infekcijas suņiem un kaķiem.

for the treatment of skin and soft tissue infections including pyoderma, wounds and abscesses associated with staphylococcus intermedius, β haemolytic streptococci, escherichia coli and/ or pasteurella multocida.
lieto ādas un mīksto audu infekciju, tajā skaitā piodermas,, brūču infekciju un abscesu ārstēšanai, kuru ierosinātāji ir staphylococcus intermedius, beta- hemolītiskie streptokoki, escherichia coli un/ vai pasteurella multocida.

treatment of: acute infections of the upper respiratory tract caused by susceptible strains of pasteurella multocida, escherichia coli and the staphylococcus intermedius group (including
Ārstēšanai: akūtas augšējo elpošanas ceļu infekcijas, ko ierosina jutīgi pasteurella multocida, escherichia coli un staphylococcus intermedius grupas (t.sk. s.pseudintermedius) celmi.

streptococcus anginosus group* (includes s. anginosus, s. intermedius and s. constellatus) streptococcus pyogenes*
streptococcus anginosus grupa* (ietver s. anginosus, s. intermedius un s. constellatus) streptococcus pyogenes

treatment of: • acute uncomplicated urinary tract infections caused by escherichia coli or staphylococcus spp • superficial pyoderma caused by staphylococcus intermedius.
suņiem: • akūtu nekomplicētu urīntrakta infekciju ārstēšanai, kuru ierosina escherichia coli vai staphylococcus spp • virsējās piodermas ārstēšanai, kuru ierosina staphylococcus intermedius.

for the treatment of: • acute uncomplicated urinary tract infections caused by escherichia coli or staphylococcus spp. • superficial pyoderma caused by staphylococcus intermedius.
- akūtas nekomplicētas urīntrakta infekcijas, kuras ierosina escherichia coli vai staphylococcus

dicural 50 mg/ ml solution for injection is indicated for the treatment of: • acute uncomplicated urinary tract infections caused by escherichia coli or staphylococcus spp • superficial pyoderma caused by staphylococcus intermedius.
dicural 50 mg/ ml šķīdums injekcijām ir indicēts: • escherichia coli vai staphylococcus spp ierosinātu akūtu nekomplicētu urīntrakta infekciju ārstēšanai, • staphylococcus intermedius ierosinātas virsējās piodermas ārstēšanai.